ד"ר דקל רועי

Articles Published

1. Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y.
Galectin-8. A new rat lectin, related to galectin-4.
J Biol Chem. 1995;270(7):3447-53.
IF 4.125; BIOCHEMISTRY & MOLECULAR BIOLOGY 74/290 – Q2; Cited: 143

2. Dekel R, Zvibel I, Brill S, Brazovsky E, Halpern Z, Oren R.
Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model.
Dig Dis Sci. 2003;48(8):1642-7.
IF 2.875; GASTROENTEROLOGY & HEPATOLOGY 39/79 – Q2; Cited: 35

3. Gur E, Deckel R (Dekel R), Zvibel I, Brazovsky E, Kariv R, Brill S, Halpern Z, Oren R.
A novel method for liver repopulation: Heterografting of micro-liver slices in a rat model.
Liver Transpl. 2003;9(4):421-4.
IF 3.91; SURGERY 20/197 – Q1, TRANSPLANTATION 6/25 – Q1; Cited: 2

4. Dekel R, Pearson T, Wendel C, De Garmo P, Fennerty MB, Fass R.
Assessment of oesophageal motor function in patients with dysphagia or chest pain - the Clinical Outcomes Research Initiative experience.
Aliment Pharmacol Ther. 2003;18(11-12):1083-9.
IF 3.201; GASTROENTEROLOGY & HEPATOLOGY 16/50 – Q2; Cited: 69

5. Dekel R, Wakelin DE, Wendel C, Green C, Sampliner RE, Garewal HS, Martinez P, Fass R.
Progression or regression of Barrett's esophagus – is it all in the eye of the beholder?
Am J Gastroenterol. 2003 Dec;98(12):2612-5.
IF 9.566; GASTROENTEROLOGY & HEPATOLOGY 6/79 – Q1; Cited: 29

6. Dekel R, Martinez-Hawthorne SD, Guillen RJ, Fass R.
Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
J Clin Gastroenterol. 2004;38(1):24-9.
IF 3.328; GASTROENTEROLOGY & HEPATOLOGY 31/79 – Q2; Cited: 28

7. Dekel R, Carraway RE, Green C, Fass R.
The relationship between the esophageal tissue content of neurotensin and the presence or absence of esophageal inflammation.
Dig Dis Sci. 2004;49(1):42-7.
IF 2.875; GASTROENTEROLOGY & HEPATOLOGY 39/79 – Q2; Cited: 0

8. Wong WM, Bautista J, Dekel R, Malagon IB, Tuchinsky I, Green C, Dickman R, Esquivel R, Fass R.
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring – a randomized trial.
Aliment Pharmacol Ther. 2005;21(2):155-63.
IF 3.201; GASTROENTEROLOGY & HEPATOLOGY 16/50 – Q2; Cited: 71

9. Kariv R, Tiomny E, Grenshpon R, Dekel R, Waisman G, Ringel Y, Halpern Z.
Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study.
Dig Dis Sci. 2006;51(12):2128-33.
IF 2.875; GASTROENTEROLOGY & HEPATOLOGY 39/79 – Q2; Cited: 13

10. Dvorak K, Fass R, Dekel R, Payne CM, Chavarria M, Dvorakova B, Bernstein H, Bernstein C, Garewal H.
Esophageal acid exposure at pH < or = 2 is more common in Barrett's esophagus patients and is associated with oxidative stress.
Dis Esophagus. 2006;19(5):366-72.
IF GASTROENTEROLOGY & HEPATOLOGY; 49/79 – Q3; Cited: 23

11. Dickman R, Green C, Fass SS, Quan SF, Dekel R, Risner-Adler S, Fass R.
Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease.
J Clin Sleep Med. 2007;3(5):505-13.
IF 3.429; CLINICAL NEUROLOGY 56/194 – Q2; Cited: 52

12. Shapiro M, Green C, Bautista JM, Dekel R, Risner-Adler S, Whitacre R, Graver E, Fass R.
Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease.
Aliment Pharmacol Ther. 2007 Jan 1;25(1):93-101.
IF 3.201; GASTROENTEROLOGY & HEPATOLOGY 16/50 – Q2; Cited: 30

13. Hod K, Dickman R, Sperber A, Melamaed S, Dekel R, Ron Y, Halpern Z, Belrliner S, Maharshak N.
Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome.
Neurogastroenterol Motil. 2010;16(2):113-9.
IF 3.617; CLINICAL NEUROLOGY 44/194 – Q1; GASTROENTEROLOGY&HEPATOLOGY 24/79-Q2; Cited: 15

14. Ron Y, Halpern Z, Safadi R, Dickman R, Dekel R, Sperber AD.
Safety and efficacy of the vibrating capsule, an innovative non-pharmacological treatment modality for chronic constipation. Neurogastroenterol Motil. 2015;27(1):99-104.
IF 3.617; CLINICAL NEUROLOGY 44/194 – Q1; GASTROENTEROLOGY&HEPATOLOGY 24/79-Q2; Cited: 3

15. Hod K, Sperber AD, Ron Y, Boaz M, Dickman R, Berliner S, Halpern Z, Maharshak N, Dekel R.
A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
Neurogastroenterol Motil. 2017 Jul;29(7).
IF 3.617; CLINICAL NEUROLOGY 44/194 – Q1; GASTROENTEROLOGY&HEPATOLOGY 24/79-Q2; Cited: 1

16. Hod K, Melamed S, Dekel R, Maharshak N, Sperber AD. Burnout, but not job strain, is associated with irritable bowel syndrome in working adults. J Psychosom Res. 2020;134:110121. doi:10.1016/j.jpsychores.2020.110121

17. Hod K, Sperber AD, Maharshak N, et al. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls. Neurogastroenterol Motil. 2018;30(12):e13464. doi:10.1111/nmo.13464

18. Hod K, Dekel R, Aviv Cohen N, et al. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2018;30(12):e13456. doi:10.1111/nmo.13456

19. Winder O, Fliss-Isakov N, Winder G, et al. Clinical outcomes of endoscopic balloon dilatation of intestinal strictures in patients with Crohn's disease. Medicine (Baltimore). 2019;98(35):e16864. doi:10.1097/MD.0000000000016864

Case Reports published

Tzfoni I, Chayo J, Shaked M, et al. Pancreatic cancer in bloom syndrome. SAGE Open Med Case Rep. 2019;7:2050313X19855587. Published 2019 Jun 4. doi:10.1177/2050313X19855587

Review Articles Published

1. Dekel R, Fass R. Current perspectives on the diagnosis and treatment of functional esophageal disorders. Curr Gastroenterol Rep. 2003;5(4):314-22.

2. Dekel R, Morse C, Fass R. The role of proton pump inhibitors in gastro-oesophageal reflux disease. Drugs. 2004;64(3): 277-95.

3. Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next? Aliment Pharmacol Ther. 2005;22(2):79-94.

4. Sperber AD, Dekel R. Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. J Neurogastroenterol Motil. 2010 Apr;16(2):113-9. 5. Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22(3):329-39.

Chapters in books

1. Dekel R, Fass R.
Nonerosive Reflux Disease.
In: GERD/Dyspepsia. Hot topics GERD/Dyspepsia, Fass R (ed.), Chap. 6, pp.101-107. Hanley & Belfus, 2004.

2. Dekel R, Sperber AD.
Chronic functional abdominal pain.